NEXGEL, Inc (NXGL) - Multiplikator forward rega marang pendapatan
NEXGEL, Inc. (NXGL) develops advanced hydrogel patches for prolonged drug delivery. The estimated forward P/S exhibits a downward trend, where the 0.20 mark characterizes this parameter. Polymer import risks and logistical disruptions are offset by stable demand in dermatology, which sustains high business margins amid a general macroeconomic upturn for specialized medical devices.
NEXGEL Inc - rincian analitis lan metrik utama (NXGL)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas NEXGEL, Inc.|NXGL - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas NEXGEL, Inc.|NXGL - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku NEXGEL Inc|NXGL - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan NEXGEL|Rasio cepet nexgel.com
- data bathi bisnis lan rasio investasi:
NXGL - Penghasilan resik perusahaan|Bathi mangsa ngarep NEXGEL, Inc.|NXGL - Pangali rega marang bathi|Pangali Forward P/E NEXGEL, Inc|NXGL - Rasio rega marang wutah bathi resik|Pangali EV/EBITDA NEXGEL Inc|NXGL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan NEXGEL|NXGL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan nexgel.com|NXGL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep NEXGEL, Inc.
- data dodolan lan asil:
Analisis umum perusahaan:NXGL (NEXGEL)
Assessing the investment attractiveness of NEXGEL, Inc. (NXGL) requires analyzing the ratio of market capitalization to projected revenue to identify potential asset overvaluation. The forward P/S ratio demonstrates how many years of revenue an investor is paying per share today, which is critical as the company scales B2B contracts for hydrogel product manufacturing and develops its own e-commerce sales channels.
Analisis perusahaan pesaing
Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|AtriCure Corp (ATRC) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan STAA|NAGE (ChromaDex Corporation) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep zimvie.com ZIMV|Multiplikator forward rega marang pendapatan ANGO (AngioDynamics)|Cerus Corp. - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S TKNO (Alpha Teknova Inc)|Prakiraan rega marang pendapatan Monogram Orthopedics Inc.|Sharps Tech - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep InfuSystem Holdings|Utah Medical Products, Inc. (UTMD) - Rasio rega marang prakiraan pendapatan|KRMD (KORU Medical) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan NYXH|MBOT: Rega forward marang dodolan|Multiplikator Forward P/S PDEX|Rasio kapitalisasi marang dodolan sing dikarepake zentek.com|Rasio rega marang prakiraan pendapatan Elutia ELUT|MLSS: Kapitalisasi marang prakiraan pendapatan|Retractable Tech - Multiplikator Forward P/S|harvardbioscience.com (HBIO) - Multiplikator forward rega marang pendapatan|FEMY (Femasys Inc.) - Multiplikator forward rega marang pendapatan|MHUA - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|Kapitalisasi marang prakiraan pendapatan CJMB (Callan JMB Corp)|Multiplikator forward rega marang pendapatan ATRI (Atrion Corp)|NeuroMetrix Corporation - Kapitalisasi marang prakiraan pendapatan
